Clinical Trials Browser

Phase 1/2 × Completed × ofatumumab × Clear all

NCT01060384 2023-10-04

Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 1/2 Completed

46 enrolled 8 charts

Lymphoma, Non-Hodgkin

NCT01217749 2015-06-25

PCYC-1109-CA

Phase 1/2 Completed

71 enrolled 10 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell